These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4047460)

  • 1. [Idiopathic hypereosinophilic syndrome. Current clinico-therapeutic state].
    Mercadanti M; Cavalieri F; Ferraccioli GF; Ambanelli U
    Minerva Med; 1985 Oct; 76(39):1781-90. PubMed ID: 4047460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypereosinophilic syndrome evolving to acute lymphoblastic leukemia.
    Takai K; Sanada M
    Int J Hematol; 1991 Jun; 54(3):231-9. PubMed ID: 1747458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of fifteen patients with the hypereosinophilic syndrome.
    Spry CJ; Davies J; Tai PC; Olsen EG; Oakley CM; Goodwin JF
    Q J Med; 1983; 52(205):1-22. PubMed ID: 6878618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome.
    Foong A; Scholes JV; Gleich GJ; Kephart GM; Holt PR
    Hepatology; 1991 Jun; 13(6):1090-4. PubMed ID: 2050327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eosinophilia-associated muscle disorders: an immunohistological study with tissue localisation of major basic protein in distinct clinicopathological forms.
    Cantarini L; Volpi N; Carbotti P; Greco G; Aglianò M; Bellisai F; Giannini F; Alessandrini C; Grasso G; Galeazzi M
    J Clin Pathol; 2009 May; 62(5):442-7. PubMed ID: 19139036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic vasculitis associated with eosinophilia and marked degranulation of tissue eosinophils.
    Fischer TJ; Daugherty C; Gushurst C; Kephart GM; Gleich GJ
    Pediatrics; 1988 Jul; 82(1):69-75. PubMed ID: 3380602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eosinophilic myositis with eosinophilic cellulitislike skin lesions. Association with increased serum levels of eosinophil cationic protein and interleukin-5.
    Trüeb RM; Lübbe J; Torricelli R; Panizzon RG; Wüthrich B; Burg G
    Arch Dermatol; 1997 Feb; 133(2):203-6. PubMed ID: 9041834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-2 primes eosinophil degranulation in hypereosinophilia and Wells' syndrome.
    Simon HU; Plötz S; Simon D; Seitzer U; Braathen LR; Menz G; Straumann A; Dummer R; Levi-Schaffer F
    Eur J Immunol; 2003 Apr; 33(4):834-9. PubMed ID: 12672048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypereosinophilic syndrome: dramatic response to therapeutic intervention.
    Parrillo JE; Fauci AS; Wolff SM
    Trans Assoc Am Physicians; 1977; 90():135-44. PubMed ID: 611659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective priming of peripheral blood eosinophils in patients with idiopathic hypereosinophilic syndrome.
    Lampinen M; Oberg G; Venge P; Carlson M
    APMIS; 2006 Nov; 114(11):757-63. PubMed ID: 17078855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Practical approach to hypereosinophilia].
    Roufosse F; Cogan E
    Rev Med Brux; 2008 Sep; 29(4):400-8. PubMed ID: 18949995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic hypereosinophilic syndrome with restrictive cardiomyopathy--a case report.
    Sakhuja V; Manjunath S; Varma S; Anand IS
    Indian Heart J; 1987; 39(1):82-4. PubMed ID: 3450575
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A; Yamazaki K; Suzuki K; Sato S
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benign idiopathic hypereosinophilia: a feeble masquerader or a smouldering form of the hypereosinophilic syndrome?
    Confalonieri M; Tacconi F; De Amici M; Maccario R; Porta C; Gioglio L; Bobbio-Pallavicini E
    Haematologica; 1995; 80(1):50-3. PubMed ID: 7758993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The hypereosinophilic syndrome: case report].
    Mikołajczyk K; Zaba R; Walkowiak B; Grzybowski G; Samborski W
    Ann Acad Med Stetin; 2006; 52 Suppl 2():65-9. PubMed ID: 17471838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered density, metabolism and surface receptors of eosinophils in eosinophilia.
    Winqvist I; Olofsson T; Olsson I; Persson AM; Hallberg T
    Immunology; 1982 Nov; 47(3):531-9. PubMed ID: 7129529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Tissue hypereosinophilia].
    Desreumaux P; Wallaert B; Janin A
    Rev Prat; 2000 Mar; 50(6):630-5. PubMed ID: 10808320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.
    Fauci AS; Harley JB; Roberts WC; Ferrans VJ; Gralnick HR; Bjornson BH
    Ann Intern Med; 1982 Jul; 97(1):78-92. PubMed ID: 7046556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective therapy for a severe case of the idiopathic hypereosinophilic syndrome.
    Marshall GM; White L
    Am J Pediatr Hematol Oncol; 1989; 11(2):178-83. PubMed ID: 2665548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The clinico-pathological manifestation of cardiac involvement in eosinophilic diseases].
    Tian Z; Fang Q; Zhao DC; Cui QC; Liu YT; Zeng Y; Li MT; Jiang XC
    Zhonghua Nei Ke Za Zhi; 2010 Aug; 49(8):684-7. PubMed ID: 20979789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.